Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.


Importance:Improvements in symptoms, functional capacity, and quality of life are among the key goals of edge-to-edge transcatheter mitral valve repair (TMVR) for mitral regurgitation. Objective:To examine health status outcomes among patients undergoing TMVR in clinical practice and the factors associated with improvement. Design, Setting, and Participants:This cohort study used the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry, which contains data on patients with severe mitral regurgitation treated with TMVR from 2013 through 2017 in 217 US hospitals. Main Outcomes and Measures:Change in disease-specific health status (Kansas City Cardiomyopathy Questionnaire-Overall Summary score [KCCQ-OS]; range 0-100 points, with higher scores indicating better health status) at 30 days and 1 year after TMVR. We also examined factors associated with health status at 30 days after TMVR, by means of multivariable linear regression using a generalized estimating equations approach to account for clustering of patients within sites. Results:The KCCQ data were available in 81.2% at baseline, 69.3% of survivors at 30 days, and 47.4% of survivors at 1 year. Among 4226 patients who underwent TMVR, survived 30 days, and completed the KCCQ at baseline and follow-up, the KCCQ-OS increased from 41.9 before TMVR to 66.7 at 30 days (mean change 24.8 [95% CI, 24.0-25.6] points; P < .001), representing a large clinical improvement. The KCCQ scores remained stable from 30 days to 1 year after TMVR, with no further significant increase or decline. On multivariable analysis, atrial fibrillation (-2.2 [95% CI, -3.7 to -0.6] points; P = .01), permanent pacemaker (-2.1 [95% CI, -3.7 to -0.4] points; P = .01), severe lung disease (-3.9 [95% CI, -6.2 to -1.5] points; P = .001), home oxygen (-2.7 [95% CI, -4.9 to -0.4] points; P = .02), and lower KCCQ scores at baseline (3.9 points for each 10-point increase [95% CI, 3.6-4.2]; P < .001) were independently associated with lower 30-day KCCQ-OS scores. In-hospital renal failure was uncommon but was also associated with significant reductions in 30-day KCCQ-OS scores (-7.3 [95% CI -13.3 to -1.2] points). In estimates calculated with inverse probability weighting, after 1 year after TMVR, 54.2% (95% CI 52.2%-56.1%) of patients were alive and well; 23.0% had died, 21.9% had persistently poor health status (KCCQ-OS <60 points), 5.5% had a health status decline from baseline, and 4.6% had both poor health status and health status decline. Conclusions and Relevance:In a national cohort of US patients undergoing edge-to-edge TMVR in clinical practice, health status was impaired prior to the procedure, improved within 30 days, and remained stable through 1 year among surviving patients with available data. While long-term mortality remains high, most surviving patients demonstrate improvements in symptoms, functional status, and quality of life, with only modest differences by patient-level factors.


JAMA Cardiol


JAMA cardiology


Arnold SV,Li Z,Vemulapalli S,Baron SJ,Mack MJ,Kosinski AS,Reynolds MR,Hermiller JB,Rumsfeld JS,Cohen DJ




Has Abstract


2018-12-01 00:00:00














  • Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.

    abstract:Importance:Racial differences are recognized in multiple cardiovascular parameters, including left ventricular hypertrophy and heart failure, which are 2 major manifestations of hypertrophic cardiomyopathy. The association of race with disease expression and outcomes among patients with hypertrophic cardiomyopathy is n...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Eberly LA,Day SM,Ashley EA,Jacoby DL,Jefferies JL,Colan SD,Rossano JW,Semsarian C,Pereira AC,Olivotto I,Ingles J,Seidman CE,Channaoui N,Cirino AL,Han L,Ho CY,Lakdawala NK

    更新日期:2020-01-01 00:00:00

  • Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project.

    abstract:Importance:Physicians have been criticized for having an overly enthusiastic response to new device approvals, especially for novel technologies. However, to our knowledge, the rates of new product adoption and patterns of new device usage in clinical practice have not been well described. Objective:To characterize th...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Chau KH,Kennedy KF,Messenger JC,Garratt KN,Maddox TM,Yeh RW,Kirtane AJ

    更新日期:2019-06-01 00:00:00

  • Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.

    abstract:Importance:Many of the quality measures used to assess accountable care organization (ACO) performance in the Medicare Shared Savings Program (MSSP) focus on disease control and medication use among patients with cardiovascular disease and diabetes. To date, the association between participation in the MSSP by provider...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: McWilliams JM,Najafzadeh M,Shrank WH,Polinski JM

    更新日期:2017-09-01 00:00:00

  • Association Between Reproductive Life Span and Incident Nonfatal Cardiovascular Disease: A Pooled Analysis of Individual Patient Data From 12 Studies.

    abstract:Importance:Early menarche and early menopause are associated with increased risk of cardiovascular disease (CVD) in midlife, but little is known about the association between reproductive life span and the risk of CVD. Objective:To investigate the association between the length of reproductive life span and risk of in...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Mishra SR,Chung HF,Waller M,Dobson AJ,Greenwood DC,Cade JE,Giles GG,Bruinsma F,Simonsen MK,Hardy R,Kuh D,Gold EB,Crawford SL,Derby CA,Matthews KA,Demakakos P,Lee JS,Mizunuma H,Hayashi K,Sievert LL,Brown DE,Sandi

    更新日期:2020-09-16 00:00:00

  • Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 Individuals.

    abstract:Importance:Despite considerable improvements in heart failure care, mortality rates among patients in high-income countries have changed little since the early 2000s. Understanding the reasons underlying these trends may provide valuable clues for developing more targeted therapies and public health strategies. Object...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Conrad N,Judge A,Canoy D,Tran J,Pinho-Gomes AC,Millett ERC,Salimi-Khorshidi G,Cleland JG,McMurray JJV,Rahimi K

    更新日期:2019-11-01 00:00:00

  • Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition.

    abstract:Importance:Low-density lipoprotein cholesterol (LDL-C) is an important modifiable risk factor for atherosclerotic cardiovascular disease. It is unclear whether the percentage LDL-C lowering with pharmacotherapies differs on the basis of baseline LDL-C levels. Objective:To evaluate the association between baseline LDL-...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Marcusa DP,Giugliano RP,Park JG,de Lemos JA,Cannon CP,Sabatine MS

    更新日期:2020-11-13 00:00:00

  • Comparison of Approaches for Heart Failure Case Identification From Electronic Health Record Data.

    abstract:Importance:Accurate, real-time case identification is needed to target interventions to improve quality and outcomes for hospitalized patients with heart failure. Problem lists may be useful for case identification but are often inaccurate or incomplete. Machine-learning approaches may improve accuracy of identificatio...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Blecker S,Katz SD,Horwitz LI,Kuperman G,Park H,Gold A,Sontag D

    更新日期:2016-12-01 00:00:00

  • Adjunctive Antithrombotic Therapy for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

    abstract:Importance:Transcatheter aortic valve replacement (TAVR) is an established alternative to surgery for patients with severe symptomatic aortic stenosis. Adjunctive antithrombotic therapy used to mitigate thrombotic risks in patients undergoing TAVR must be balanced against bleeding complications, since both are associat...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,评审


    authors: Saito Y,Nazif T,Baumbach A,Tchétché D,Latib A,Kaple R,Forrest J,Prendergast B,Lansky A

    更新日期:2020-01-01 00:00:00

  • Sex Differences in Blood Pressure Trajectories Over the Life Course.

    abstract:Importance:If we assume that women and men exhibit variations of the same fundamental vascular physiology, then conventional analyses of subclinical measures would suggest that women catch up to men by midlife in the extent of potentially important vascular disease. Alternatively, under the assumption that vascular phy...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Ji H,Kim A,Ebinger JE,Niiranen TJ,Claggett BL,Bairey Merz CN,Cheng S

    更新日期:2020-03-01 00:00:00

  • Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting.

    abstract:IMPORTANCE:Reduced rates of cardiac catheterization, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) are an unintended consequence of public reporting of cardiogenic shock outcomes in New York. OBJECTIVES:To evaluate whether the referral rates for cardiac catheterization, PCI, or CABG...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Bangalore S,Guo Y,Xu J,Blecker S,Gupta N,Feit F,Hochman JS

    更新日期:2016-09-01 00:00:00

  • Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure.

    abstract:Importance:Medicare Advantage (MA), a private insurance plan option, now covers one-third of all Medicare beneficiaries. Although patients with cardiovascular disease enrolled in MA have been reported to receive higher quality of care in the ambulatory setting than patients enrolled in fee-for-service (FFS) Medicare, i...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Figueroa JF,Wadhera RK,Frakt AB,Fonarow GC,Heidenreich PA,Xu H,Lytle B,DeVore AD,Matsouaka R,Yancy CW,Bhatt DL,Joynt Maddox KE

    更新日期:2020-09-02 00:00:00

  • Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure: Proposal of a Novel Mechanism of Action.

    abstract:Importance:Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducing the risk of the development or progression of heart failure. In a landmark trial called Empagliflozin, Cardiovascular Outcomes, and M...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Packer M,Anker SD,Butler J,Filippatos G,Zannad F

    更新日期:2017-09-01 00:00:00

  • Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life.

    abstract:Importance:Long-term blood pressure (BP) variability has emerged as a reproducible measure that is associated with heart failure independent of systemic BP. Visit-to-visit BP variability may be associated with the risk of heart failure early in the life course and thus may be reflected in subclinical alterations in car...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究


    authors: Nwabuo CC,Yano Y,Moreira HT,Appiah D,Vasconcellos HD,Aghaji QN,Viera A,Rana JS,Shah RV,Murthy VL,Allen NB,Schreiner PJ,Lloyd-Jones DM,Lima JAC

    更新日期:2020-07-01 00:00:00

  • Cardiac Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome.

    abstract:Importance:Hutchinson-Gilford progeria syndrome (HGPS) is an ultrarare disorder associated with premature death due to cardiovascular events during the second decade of life. However, because of its rarity (107 identified living patients), the natural history of cardiac disease remains uncharacterized. Therefore, meani...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Prakash A,Gordon LB,Kleinman ME,Gurary EB,Massaro J,D'Agostino R Sr,Kieran MW,Gerhard-Herman M,Smoot L

    更新日期:2018-04-01 00:00:00

  • Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.

    abstract:IMPORTANCE:Dyslipidemia in young adults in the United States during their childbearing years is common, and the consequences for the next generation are poorly understood. Further understanding of the harmful consequences of elevated low-density lipoprotein cholesterol (LDL-C) levels in young adults may help to inform ...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Mendelson MM,Lyass A,O'Donnell CJ,D'Agostino RB Sr,Levy D

    更新日期:2016-04-01 00:00:00

  • Long-term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization.

    abstract:Importance:The optimal conduits for coronary artery bypass grafting (CABG) remain controversial in multivessel coronary artery disease. Objective:To compare the long-term clinical outcomes of total arterial revascularization (TAR) vs non-TAR (CABG with at least 1 arterial and 1 saphenous vein graft) in a multicenter p...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究


    authors: Rocha RV,Tam DY,Karkhanis R,Wang X,Austin PC,Ko DT,Gaudino M,Royse A,Fremes SE

    更新日期:2020-05-01 00:00:00

  • Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk Mandate.

    abstract:Importance:High-resolution stratification of risk of sudden cardiac arrest (SCA) in individual patients is a tool that is necessary for achieving effective and efficient application of data generated by population-based research. This concept is at the core of initiatives for merging cost effectiveness with maximized c...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,评审


    authors: Myerburg RJ,Goldberger JJ

    更新日期:2017-06-01 00:00:00

  • Outpatient Worsening Heart Failure as a Target for Therapy: A Review.

    abstract:Importance:Hospitalizations for worsening heart failure (WHF) represent an enormous public health and financial burden, with physicians, health systems, and payers placing increasing emphasis on hospitalization prevention. In addition, maximizing time out of the hospital is an important patient-centered outcome. In thi...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Greene SJ,Mentz RJ,Felker GM

    更新日期:2018-03-01 00:00:00

  • Myocarditis in Duchenne Muscular Dystrophy After Changing Steroids.

    abstract:Importance:Cardiac dysfunction is a leading cause of morbidity and mortality in Duchenne muscular dystrophy (DMD). This case highlights the importance of steroids in treating cardiac complications of DMD and the dangers of discontinuing or switching between steroid classes. Objective:To recognize the presentation of a...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Abutaleb ARA,McNally EM,Khan SS,Anderson AS,Carr JC,Wilcox JE

    更新日期:2018-10-01 00:00:00

  • Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis.

    abstract:Importance:As many as 10% of women experience natural menopause by the age of 45 years. If confirmed, an increased risk of cardiovascular disease (CVD) and all-cause mortality associated with premature and early-onset menopause could be an important factor affecting risk of disease and mortality among middle-aged and o...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,meta分析,评审


    authors: Muka T,Oliver-Williams C,Kunutsor S,Laven JS,Fauser BC,Chowdhury R,Kavousi M,Franco OH

    更新日期:2016-10-01 00:00:00

  • Feasibility, Process, and Outcomes of Cardiovascular Clinical Trial Data Sharing: A Reproduction Analysis of the SMART-AF Trial.

    abstract:Importance:Data sharing is as an expanding initiative for enhancing trust in the clinical research enterprise. Objective:To evaluate the feasibility, process, and outcomes of a reproduction analysis of the THERMOCOOL SMARTTOUCH Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (SMART-AF) trial u...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Gay HC,Baldridge AS,Huffman MD

    更新日期:2017-12-01 00:00:00

  • Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.

    abstract:Importance:Limited evidence is available regarding the benefit and hazard of higher-intensity treatment to lower lipid levels among patients 75 years or older. As a result, guideline recommendations differ for this age group compared with younger patients. Objective:To determine the effect on outcomes and risks of com...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究,随机对照试验


    authors: Bach RG,Cannon CP,Giugliano RP,White JA,Lokhnygina Y,Bohula EA,Califf RM,Braunwald E,Blazing MA

    更新日期:2019-09-01 00:00:00

  • Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.

    abstract:Importance:In clinical trials, transcatheter aortic valve replacement (TAVR) has been shown to improve symptoms and quality of life. As this technology moves into general clinical practice, evaluation of the health status outcomes among unselected patients treated with TAVR is of critical importance. Objective:To exam...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究


    authors: Arnold SV,Spertus JA,Vemulapalli S,Li Z,Matsouaka RA,Baron SJ,Vora AN,Mack MJ,Reynolds MR,Rumsfeld JS,Cohen DJ

    更新日期:2017-04-01 00:00:00

  • Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial.

    abstract:Importance:Sustained reductions in low-density lipoprotein cholesterol (LDL-C) with lipid-lowering therapies that require frequent dosing are reliant on patient adherence, and poor adherence is associated with worse clinical outcomes. Objective:To determine whether inclisiran, a small interfering RNA, reduces mean LDL...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,随机对照试验


    authors: Ray KK,Stoekenbroek RM,Kallend D,Nishikido T,Leiter LA,Landmesser U,Wright RS,Wijngaard PLJ,Kastelein JJP

    更新日期:2019-11-01 00:00:00

  • Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

    abstract:Importance:Persons with human immunodeficiency virus (HIV) that is treated with antiretroviral therapy have improved longevity but face an elevated risk of myocardial infarction (MI) due to common MI risk factors and HIV-specific factors. Despite these elevated MI rates, optimal methods to predict MI risks for HIV-infe...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究


    authors: Feinstein MJ,Nance RM,Drozd DR,Ning H,Delaney JA,Heckbert SR,Budoff MJ,Mathews WC,Kitahata MM,Saag MS,Eron JJ,Moore RD,Achenbach CJ,Lloyd-Jones DM,Crane HM

    更新日期:2017-02-01 00:00:00

  • Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.

    abstract:Importance:The period following heart failure hospitalization (HFH) is a vulnerable time with high rates of death or recurrent HFH. Objective:To evaluate clinical characteristics, outcomes, and treatment response to vericiguat according to prespecified index event subgroups and time from index HFH in the Vericiguat Gl...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Lam CSP,Giczewska A,Sliwa K,Edelmann F,Refsgaard J,Bocchi E,Ezekowitz JA,Hernandez AF,O'Connor CM,Roessig L,Patel MJ,Pieske B,Anstrom KJ,Armstrong PW,VICTORIA Study Group.

    更新日期:2020-11-13 00:00:00

  • Frequency and Outcomes of Preoperative Stress Testing in Total Hip and Knee Arthroplasty from 2004 to 2017.

    abstract:Importance:Cardiac stress testing is often performed prior to noncardiac surgery, although trends in use of preoperative stress testing and the effect of testing on cardiovascular outcomes are currently unknown. Objective:To describe temporal trends and outcomes of preoperative cardiac stress testing from 2004 to 2017...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Rubin DS,Hughey R,Gerlach RM,Ham SA,Ward RP,Nagele P

    更新日期:2021-01-01 00:00:00

  • Cardiac Stress Test Trends Among US Patients Younger Than 65 Years, 2005-2012.

    abstract:Importance:After a period of rapid growth, use of cardiac stress testing has recently decreased among Medicare beneficiaries and in a large integrated health system. However, it is not known whether declines in cardiac stress testing are universal or are confined to certain populations. Objective:To determine trends i...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Kini V,McCarthy FH,Dayoub E,Bradley SM,Masoudi FA,Ho PM,Groeneveld PW

    更新日期:2016-12-01 00:00:00

  • Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study.

    abstract:Importance:The Open-Label Study of Long-term Evaluation Against LDL-C (OSLER-1) evaluated the durability of long-term efficacy and safety during long-term therapy with evolocumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9). Objective:To determine whether LDL-C level reductions ...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Koren MJ,Sabatine MS,Giugliano RP,Langslet G,Wiviott SD,Kassahun H,Ruzza A,Ma Y,Somaratne R,Raal FJ

    更新日期:2017-06-01 00:00:00

  • Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab.

    abstract:Importance:Levels of proprotein convertase subtilisin kexin type 9 (PCSK9) vary markedly across the population and are influenced by genetic and nongenetic factors. Evolocumab is a fully human, monoclonal antibody against PCSK9 that reduces low-density lipoprotein cholesterol (LDL-C) levels by 55% to 75%. Whether the e...

    journal_title:JAMA cardiology

    pub_type: 杂志文章


    authors: Desai NR,Giugliano RP,Wasserman SM,Gibbs JP,Liu T,Scott R,Sabatine MS

    更新日期:2017-05-01 00:00:00